What's Happening?
The Environmental Protection Agency (EPA) is moving forward with its review of four chemicals under the Toxic Substances Control Act (TSCA): 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta [g]-2-benzopyran (HHCB), phthalic anhydride, o-dichlorobenzene
(oDCB), and p-dichlorobenzene (pDCB). The agency has released draft documents for public comment and independent scientific peer review by the Science Advisory Committee on Chemicals (SACC). These chemicals are commonly found in various products, including fragrances, paints, coatings, cleaners, and industrial processes. The EPA's draft risk evaluation for HHCB, a fragrance ingredient, indicates no unreasonable risk under current law across 22 conditions of use. However, for phthalic anhydride, used in paints and plastics, the draft evaluation identifies unreasonable risks to workers and consumers from dermal and inhalation exposure. For pDCB and oDCB, used in manufacturing and cleaning, draft hazard assessments confirm serious non-cancer health concerns affecting the liver, kidneys, respiratory, nervous, and reproductive systems. While current evidence suggests pDCB is not likely to cause cancer in humans and a quantitative cancer assessment for oDCB is not warranted, the EPA acknowledges ongoing concerns about long-term cancer risks. The agency is utilizing advanced scientific techniques, such as transcriptomic analysis and computational approaches, to inform these assessments.
Why It's Important?
This EPA initiative is crucial for public health and environmental safety in the U.S., as it directly addresses potential risks from chemicals prevalent in everyday products and industrial settings. The findings for phthalic anhydride, indicating unreasonable risks to workers and consumers, could lead to significant regulatory actions, impacting industries involved in manufacturing paints, coatings, adhesives, and plastics. This could necessitate changes in product formulations, manufacturing processes, and workplace safety protocols, potentially increasing operational costs for businesses but enhancing worker and consumer protection. The use of advanced molecular tools like transcriptomics in assessing pDCB and oDCB demonstrates a commitment to cutting-edge science in regulatory decision-making, potentially setting new standards for chemical risk evaluation. The emphasis on peer review and public comment ensures transparency and scientific rigor, fostering trust in the EPA's conclusions. For families and advocates concerned about long-term cancer risks, this process provides an avenue for their input to directly influence the final risk evaluations, highlighting the democratic aspect of environmental regulation. The outcomes of these reviews will shape future chemical safety standards, influencing product development and consumer exposure across various sectors.
What's Next?
Following the release of these draft documents, the EPA will hold a virtual public meeting of the SACC from June 8-12, 2026, to review the draft risk evaluations for HHCB and phthalic anhydride, and technical support documents for pDCB and oDCB. A preparatory virtual public meeting will also be held on May 26, 2026, for the SACC and the public to discuss the scope and clarity of the charge questions for the peer review. Public comments on the draft documents must be submitted within 45 days of the Federal Register Notice announcing the peer review. For HHCB and phthalic anhydride, additional public comment periods will be open for 60 days in their respective TSCA dockets. The EPA will carefully consider all feedback from the SACC and the public before finalizing the risk evaluations. If unreasonable risks are confirmed for phthalic anhydride, the EPA plans to propose risk management actions to reduce or eliminate unsafe exposures in workplaces and homes. The agency will also release draft risk evaluations for pDCB and oDCB prior to the June SACC meeting. All existing protections, regulations, and risk management measures for these chemicals remain in effect during this review process.
Beyond the Headlines
The EPA's comprehensive review of these chemicals, particularly its use of new approach methods (NAMs) like transcriptomic analysis, signifies a broader shift towards more sophisticated and potentially less animal-intensive methods in chemical risk assessment. This aligns with a growing global movement to reduce animal testing and leverage computational and in vitro studies. The agency's commitment to "radical transparency" through extensive public and peer review processes could set a precedent for future regulatory actions, enhancing public confidence in scientific assessments. However, the complexity of these advanced methods also necessitates clear communication to ensure public understanding and trust. The ongoing concerns about long-term cancer risks, even when quantitative assessments are deemed unwarranted, highlight the persistent challenge of addressing public perception and scientific uncertainty in environmental health. This process underscores the intricate balance between scientific evidence, regulatory mandates, public concerns, and industrial implications in shaping chemical safety policy in the U.S. The potential for new regulations could also spur innovation in safer chemical alternatives and more sustainable industrial practices.
